Accelerating ACV growth in the US is what is needed and it is what was delivered.
No mention of profitability yet, however, if they can keep that ACV growth going at a fast clip over the next 12 months everything should be roses.
- Forums
- ASX - By Stock
- NEA
- Ann: H1 FY2018 Preliminary Results - Record Growth
Ann: H1 FY2018 Preliminary Results - Record Growth, page-3
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online